GRAd-COV2
id:
grad-cov2-290-2343602
title:
GRAd-COV2
text:
GRAd-COV2 is a COVID-19 vaccine candidate developed by ReiThera Srl and Lazzaro Spallanzani National Institute for Infectious Diseases. It is based on a novel replication defective Gorilla Adenovirus and encodes for SARS-COV-2 full length prefusion stabilized Spike protein. More specifically, the vector used is the simian group C adenovirus GRAd32, isolated from a captive gorilla, with a genome deleted of the entire E1 and E3 regions and the native E4 region replaced with the E4 orf6 of human ad
brand slug:
wiki
category slug:
encyclopedia
description:
Vaccine candidate against COVID-19
original url:
https://en.wikipedia.org/wiki/GRAd-COV2
date created:
date modified:
2023-08-24T14:35:59Z
main entity:
{"identifier":"Q98945351","url":"https://www.wikidata.org/entity/Q98945351"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Coronavirus._SARS-CoV-2.png","width":2048,"height":2048}
fields total:
13
integrity:
15